HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Study on the potential benefit of adding topical bromfenac to intravitreal injections of ranibizumab for the therapy of exudative age-related macular degeneration.

AuthorsJost B Jonas, Teodosio Libondi
JournalRetina (Philadelphia, Pa.) (Retina) Vol. 33 Issue 5 Pg. 1093 (May 2013) ISSN: 1539-2864 [Electronic] United States
PMID23446656 (Publication Type: Letter, Comment)
Chemical References
  • Angiogenesis Inhibitors
  • Anti-Inflammatory Agents, Non-Steroidal
  • Antibodies, Monoclonal, Humanized
  • Benzophenones
  • Bromobenzenes
Topics
  • Angiogenesis Inhibitors (therapeutic use)
  • Anti-Inflammatory Agents, Non-Steroidal (administration & dosage)
  • Antibodies, Monoclonal, Humanized (therapeutic use)
  • Benzophenones (administration & dosage)
  • Bromobenzenes (administration & dosage)
  • Female
  • Humans
  • Male
  • Wet Macular Degeneration (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: